{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:49:18Z","timestamp":1775504958160,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1016\/s0952-7915(03)00109-2","type":"journal-article","created":{"date-parts":[[2003,9,3]],"date-time":"2003-09-03T11:09:00Z","timestamp":1062587340000},"page":"578-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":334,"title":["Chronic granulomatous disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Paul G","family":"Heyworth","sequence":"first","affiliation":[]},{"given":"Andrew R","family":"Cross","sequence":"additional","affiliation":[]},{"given":"John T","family":"Curnutte","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0952-7915(03)00109-2_BIB1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","article-title":"Genetic, biochemical, and clinical features of chronic granulomatous disease","volume":"79","author":"Segal","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease: report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB3_1","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00018-002-8520-9","article-title":"The superoxide-generating NADPH oxidase: structural aspects and activation mechanism","volume":"59","author":"Vignais","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/bcmd.2000.0347","article-title":"Hematologically important mutations: X-linked chronic granulomatous disease - second update","volume":"27","author":"Heyworth","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/bcmd.2000.0333","article-title":"Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update)","volume":"26","author":"Cross","year":"2000","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB6","doi-asserted-by":"crossref","unstructured":"Heyworth PG, Curnutte JT, Badwey JA: Structure and regulation of NADPH oxidase of phagocytic leukocytes: insights from chronic granulomatous disease. In Molecular and Cellular Basis of Inflammation. Edited by Serhan CN, Ward PA: Humana Press; 1999:165-191.","DOI":"10.1007\/978-1-59259-253-1_8"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0925-4439(01)00110-7","article-title":"Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the cytosolic gp91-phox C-terminal tail","volume":"1586","author":"Stasia","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB8","first-page":"666","article-title":"Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase asssembly","volume":"95","author":"Leusen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0925-4439(01)00106-5","article-title":"Molecular quality control machinery contributes to the leukocyte NADPH oxidase deficiency in chronic granulomatous disease","volume":"1586","author":"Lin","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB10","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood.V95.11.3548","article-title":"Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation","volume":"95","author":"Condino-Neto","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V98.2.436","article-title":"Improved superoxide-generating ability by interferon-\u03b3 due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene","volume":"98","author":"Ishibashi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00439-002-0720-8","article-title":"A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A22\u00b0) leading to the activation of a cryptic splice site in intron 4","volume":"110","author":"Stasia","year":"2002","journal-title":"Hum Genet"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.ejhg.5200523","article-title":"A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease","volume":"8","author":"Meischl","year":"2000","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s004390100551","article-title":"A second case of somatic triple mosaicism in the CYBB gene causing chronic granulomatous disease","volume":"109","author":"Noack","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0925-4439(01)00065-5","article-title":"An unusual intronic mutation in the CYBB gene giving rise to chronic granulomatous disease","volume":"1537","author":"Noack","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V91.1.252","article-title":"Somatic triple mosaicism in a carrier of X-linked chronic granulomatous disease","volume":"91","author":"De Boer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB17","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1073\/pnas.080074897","article-title":"Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation","volume":"97","author":"Ambruso","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB18","first-page":"1646","article-title":"Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human immunodeficiency","volume":"96","author":"Williams","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB19","doi-asserted-by":"crossref","first-page":"15929","DOI":"10.1074\/jbc.M010445200","article-title":"Biochemical and biological characterization of a human Rac2 GTPase mutant associated with phagocytic immunodeficiency","volume":"276","author":"Gu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB20","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1073\/pnas.88.7.2753","article-title":"Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat","volume":"88","author":"Casimir","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB21","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1172\/JCI119721","article-title":"A p47-phox pseudogene carries the most common mutation causing p47-phox-deficient chronic granulomatous disease","volume":"100","author":"Goerlach","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB22","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1182\/blood.V95.6.2150","article-title":"Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease","volume":"95","author":"Roesler","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0301-472X(00)00646-9","article-title":"Mutational analysis of patients with p47-phox-deficient chronic granulomatous disease: the significance of recombination events between the p47-phox gene (NCF1) and its highly homologous pseudogenes","volume":"29","author":"V\u00e1zquez","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V97.1.305","article-title":"Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte oxidase protein p47-phox: mutations not arising in the p47-phox pseudogenes","volume":"97","author":"Noack","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB25_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/pd.296","article-title":"Prenatal diagnosis in two families with autosomal, p47(phox)-deficient chronic granulomatous disease due to a novel point mutation in NCF1","volume":"22","author":"De Boer","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/35083070","article-title":"The PX domains of p47-phox and p40-phox bind to lipid products of PI(3)K","volume":"3","author":"Kanai","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB27","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.1038\/35087112","article-title":"PX domains: attracted by phosphoinositides","volume":"3","author":"Simonsen","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB28","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1038\/ncb0502-e110a","article-title":"Chronic granulomatous disease mutations and the PX domain","volume":"4","author":"Heyworth","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB29","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0301-472X(01)00731-7","article-title":"Gene-scan method for the recognition of carriers and patients with p47phox-deficient autosomal recessive chronic granulomatous disease","volume":"29","author":"Dekker","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB30_1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood-2002-03-0861","article-title":"Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47\u00b0 chronic granulomatous disease carrier detection","volume":"100","author":"Heyworth","year":"2002","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB31","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1182\/blood-2002-10-3060","article-title":"Association between p47-phox pseudogenes and inflammatory bowel disease","volume":"101","author":"Harbord","year":"2003","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(03)00109-2_BIB32","unstructured":"Heyworth PG: Immunodeficiency, primary: affecting the innate immune system. In: Encyclopedia of Life Sciences. London: Nature Publishing Group; 1999: URL: http:\/\/www.els.net"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791503001092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791503001092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:16:08Z","timestamp":1760602568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791503001092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0952791503001092"],"URL":"https:\/\/doi.org\/10.1016\/s0952-7915(03)00109-2","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic granulomatous disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0952-7915(03)00109-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}